MedPath

Acceptance and Commitment Therapy (ACT) for Anxious Cancer Survivors

Not Applicable
Completed
Conditions
Cancer
Interventions
Behavioral: Acceptance and Commitment Therapy (ACT) Group
Behavioral: Usual Care
Registration Number
NCT02550925
Lead Sponsor
University of Colorado, Boulder
Brief Summary

This randomized clinical trial compares group acceptance and commitment therapy (ACT) to usual care for cancer survivors experiencing anxiety following the end of cancer treatment.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
139
Inclusion Criteria
  1. Adults in the Greater Boulder/ Denver, Colorado area who had cancer and completed primary cancer treatment (surgery, chemotherapy, and/or radiation) within the previous 18 months
  2. For solid tumor cancers: Show no current evidence of disease for solid-tumor cancers (of any cancer type or initial stage). For lymphoproliferative disorders such as chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma: In remission or asymptomatic after initial treatment and are followed with active surveillance.
  3. Screen positive for anxiety symptoms on the study screener
  4. Able to speak, read, and write English fluently
  5. Willing and able to participate in an ACT group once a week for 7 weeks
  6. Willing and able to complete online questionnaires and phone interviews at designated assessment points
Exclusion Criteria
  1. Current moderate to high suicide risk
  2. History of chronic untreated trauma (unrelated to their cancer)
  3. Psychiatric hospitalization or suicide attempt in the past 5 years

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Acceptance and Commitment Therapy GroupAcceptance and Commitment Therapy (ACT) Group-
Usual CareUsual Care-
Primary Outcome Measures
NameTimeMethod
Anxiety symptomsBaseline to Post and (3- and 6-month) Follow Up

Method of assessment: questionnaire

Secondary Outcome Measures
NameTimeMethod
Depressive symptomsBaseline to Post and (3- and 6-month) Follow Up

Method of assessment: questionnaire

Sense of life meaningBaseline to Post and (3- and 6-month) Follow Up

Method of assessment: questionnaire

Medical resource useBaseline to Post and (3- and 6-month) Follow Up

Method of assessment: survey of medical care use

Fear of cancer recurrenceBaseline to Post and (3- and 6-month) Follow Up

Method of assessment: questionnaire

Fatigue / VitalityBaseline to Post and (3- and 6-month) Follow Up

Method of assessment: questionnaire

Anxiety disorder severityBaseline to Post and 6-month Follow Up

Method of assessment: diagnostic interview

Trial Locations

Locations (1)

University of Colorado Boulder

🇺🇸

Boulder, Colorado, United States

© Copyright 2025. All Rights Reserved by MedPath